A positive correlation was observed between the prevalence of metabolic syndrome and the concentrations of urinary organophosphate metabolites, consistent with previous research finding. This association may be attributed to the action of organophosphates as acetylcholinesterase inhibitors, stimulating beta cells in the islets of Langerhans. This can lead to alterations in lipid metabolism and insulin resistance, ultimately leading to metabolic syndrome development. Metabolic syndrome is a major contributor to cardiovascular disease; therefore, it is necessary to identify the risk factors unique to rural areas, such as pesticide exposure.
Keyphrases
- metabolic syndrome
- insulin resistance
- risk factors
- cardiovascular disease
- uric acid
- cardiovascular risk factors
- risk assessment
- high fat diet
- induced apoptosis
- type diabetes
- polycystic ovary syndrome
- skeletal muscle
- ms ms
- cell cycle arrest
- cell death
- signaling pathway
- mass spectrometry
- gas chromatography
- fatty acid
- weight loss